| First Author | Xu L | Year | 2023 |
| Journal | Heliyon | Volume | 9 |
| Issue | 11 | Pages | e21882 |
| PubMed ID | 38034794 | Mgi Jnum | J:358290 |
| Mgi Id | MGI:7778536 | Doi | 10.1016/j.heliyon.2023.e21882 |
| Citation | Xu L, et al. (2023) Mannan-binding lectin ameliorates renal fibrosis by suppressing macrophage-to-myofibroblast transition. Heliyon 9(11):e21882 |
| abstractText | Mannan-binding lectin (MBL) is a pattern-recognition molecule that plays a crucial role in innate immunity. MBL deficiency correlates with an increased risk of chronic kidney disease (CKD). However, the molecular mechanisms are not fully defined. Here, we established a CKD model in wild-type (WT) and MBL-deficient (MBL(-/-)) mice via unilateral ureteral obstruction (UUO). The result showed that MBL deficiency aggravated the pathogenesis of renal fibrosis in CKD mice. Strikingly, the in vivo macrophage depletion investigation revealed that macrophages play an essential role in the MBL-mediated suppression of renal fibrosis. We found that MBL limited the progression of macrophage-to-myofibroblast transition (MMT) in kidney tissues of UUO mice. Further in vitro study showed that MBL(-/-) macrophages exhibited significantly increased levels of fibrotic-related molecules compared with WT cells upon transforming growth factor beta (TGF-beta) stimulation. We demonstrated that MBL inhibited the MMT process by suppressing the production of matrix metalloproteinase 9 (MMP-9) and activation of Akt signaling. In summary, our study revealed an expected role of MBL on macrophage transition during renal fibrosis, thus offering new insight into the potential of MBL as a therapeutic target for CKD. |
